Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns. Mahase E. BMJ 2023;380:p73.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns. BMJ 2023;380:p73.
PMID: 36631154

Free Medical Abstracts
Privacy Policy